Oral administration of TFF3 expressing Lactococcus lactis successfully prevented and healed acute colitis in mice [14], which opens the possibility to achieve exposure levels sufficient to treat metabolic or inflammatory bowel diseases in humans. This evidence concerns the gene TFF3 and inflammatory bowel disease.